SIRT1-mediated deacetylation and activation of MEK/ERK pathway decreased IL-6 in spinal dorsal horn to promote

Shenghui Hu1, Fengjia Zhou1, Baoguang Lin1

  • 1Department of Radiotherapy, General Hospital of Northern Theater Command, Shenyang, China.

Neuropharmacology
|July 5, 2025
PubMed

Insights

Sirtuin 1 (SIRT1) plays a key role in opioid tolerance. Reduced SIRT1 levels promote oxycodone tolerance by increasing IL-6 expression via histone modification and MEK/ERK pathway activation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioid analgesics like oxycodone are limited by tolerance development.
  • Sirtuin 1 (SIRT1), a histone deacetylase, is investigated for its role in this process.

Purpose of the Study:

  • To elucidate the role of SIRT1 in oxycodone-induced analgesic tolerance.
  • To identify molecular mechanisms underlying tolerance development.

Main Methods:

  • Established oxycodone tolerance in adult ICR mice using the tail-flick test.
  • Utilized RT-qPCR, Western blotting, and ChIP-qPCR to analyze gene and protein expression.
  • Assessed levels of SIRT1, IL-6, histone acetylation, and MEK/ERK pathway components.

Main Results:

  • Oxycodone administration led to analgesic tolerance and reduced SIRT1 levels in the spinal cord.
  • Elevated IL-6 expression, increased H3K9ac at the IL-6 promoter, and activated MEK/ERK signaling were observed.
  • An SIRT1 agonist (SRT1720) reversed tolerance, suppressed IL-6, and normalized molecular markers.

Conclusions:

  • SIRT1 is crucial in promoting oxycodone tolerance.
  • SIRT1 facilitates tolerance by deacetylating H3K9 at the IL-6 promoter, upregulating IL-6 via the MEK/ERK pathway.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
816
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
438
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K